Recurrence Rates and Risk Factors for Primary Giant Cell Tumors Around the Knee: A Multicentre Retrospective Study in China

Pan Hu,Liming Zhao,Huilin Zhang,Xiuchun Yu,Zhen Wang,Zhaoming Ye,Sujia Wu,Shibing Guo,Guochuan Zhang,Jinghua Wang,Xianjia Ning,Yongcheng Hu,Yingze Zhang
DOI: https://doi.org/10.1038/srep36332
IF: 4.6
2016-01-01
Scientific Reports
Abstract:Giant cell tumors of the bone (GCTBs) are commonly diagnosed in Asian populations, usually around the knee. Herein, we aimed to determine the clinical characteristics, local recurrence rates, and relevant risk factors of primary GCTB around the knee. Univariate and multivariate survival analyses were used to identify the risk factors for local recurrence. Four hundred ten patients with primary GCTB around the knee, treated between March 2000 and June 2014, were recruited from 7 institutions in China. The overall local recurrence rate was 23.4%, but was higher in patients aged 20–39 years (28.5%; P = 0.039). The local recurrence rate was the highest in patients treated with intralesional curettage (53.4%), and the lowest in those treated with resection (4.9%). We found a higher risk of tumor recurrence in the proximal fibula compared to the distal femur (hazard ratio: 28.52, 95% confidence interval: 5.88–138.39; P < 0.0001), and in patients treated with curettage compared to those treated with resection (hazard ratio: 12.07, 95% confidence interval: 4.99–29.18; P < 0.0001). Thus, the tumor location must be considered when selecting the optimal surgical treatment approach to reduce the risk of local recurrence and preserve joint function, especially in young patients.
What problem does this paper attempt to address?